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Abstract Pseudomonas aeruginosa is an opportunistic
pathogen of immunocompromised hosts. In cystic fibrosis
(CF), P. aeruginosa causes acute and chronic lung infections
that result in significant morbidity and mortality. P. aerugi-
nosa possesses several traits that contribute to its ability to
colonize and persist in acute and chronic infections. These
include high resistance to antimicrobials, ability to form
biofilms, plethora of virulence products, and metabolic
versatility. In P. aeruginosa, a cell-to-cell communication
process termed quorum sensing (QS) regulates many of
these factors that contribute to its pathogenesis. Recent
evidence suggests that the CF lung environment presents a
specialized niche for P. aeruginosa. The relationship of
P. aeruginosa QS, biofilm formation, and the CF lung
environment is discussed.
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Introduction
Pseudomonas aeruginosa is a ubiquitous Gram-negative
microorganism found in many environments, such as soil
and water. P. aeruginosa is also an opportunistic pathogen
implicated in respiratory infections, urinary tract infections,
gastrointestinal infections, keratitis, otitis media, and bac-
teremia. P. aeruginosa is found in an estimated 10–20%
of all hospital-acquired infections [1]. Patients with com-
promised host defenses, such as those infected with human
immunodeficiency virus, burn patients, or those with cystic
fibrosis (CF), are susceptible to P. aeruginosa infections.
These infections are often difficult to treat using conven-
tional antibiotic therapies.
P. aeruginosa possesses a large genetic diversity that
contributes to its ability to persist in the environment and to
its pathogenesis. P. aeruginosa is able to metabolize various
carbon and nitrogen sources and can grow in either an
aerobic or anaerobic environment using several terminal
electron acceptors. P. aeruginosa is intrinsically resistant to
many antimicrobials, in part due to its multiple efflux
systems. P. aeruginosa also produces numerous virulence
factors, including secreted factors, such as elastase, pro-
teases, phospholipase C, hydrogen cyanide, exotoxin A,
and exoenzyme S, as well as cell-associated factors, such as
lipopolysaccharide, flagella, and pili.
In P. aeruginosa, expression, production, and/or secre-
tion of many virulence factors are controlled in a cell
density-dependent manner known as quorum sensing (QS).
Many bacteria, including P. aeruginosa, use QS to
coordinate population behavior by producing, sensing, and
responding to diffusible signaling molecules, termed auto-
inducers. Two complete QS systems, the las and rhl systems,
have been described and well-studied in P. aeruginosa.
These systems consist of the transcriptional regulatory
proteins LasR (in the las system) and RhlR (in the rhl
system), or R-proteins, and their cognate autoinducer
signal molecules N-(3-oxododecanoyl) homoserine lactone
(3O-C12-HSL) in the las system and N-butyryl homoserine
lactone (C4-HSL) in the rhl system. Each R-protein
possesses an autoinducer-binding domain as well as a
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deoxyribonucleic acid (DNA)-binding domain. The binding
of the R-protein to its cognate autoinducer molecule
produces a R-protein–autoinducer complex that modulates
target gene expression, presumably by binding to conserved
DNA elements termed las boxes located upstream of the
translational start site of QS-regulated genes [2]. The las and
rhl systems are not independent and are intertwined in a
hierarchical manner, with the las system exerting control
over the rhl system [3, 4]. P. aeruginosa also produces a
third signal molecule, 2-heptyl-3-hydroxy-4-quinolone or the
Pseudomonas quinolone signal (PQS), that links the las and
rhl systems [5, 6]. Incredibly, transcriptome analyses have
determined that between 6% and 10% of the P. aeruginosa
genome is regulated by the las and/or rhl systems [7–9].
P. aeruginosa also readily forms communities of cells
encased in an extracellular matrix, consisting of secreted
proteins, polysaccharides, nucleic acids, and cellular debris,
attached to abiotic or biotic surfaces [10]. These commu-
nities, known as biofilms, are of clinical relevance as the
awareness of the prevalence of biofilm-centered infections
increases. Classic examples include biofilm-mediated infec-
tions that occur on medical devices such as intravascular
catheters, urinary catheters, orthopedic devices, and dialysis
machines [11, 12]. More recently, there is evidence that
chronic infections, such as recurrent ear infections (otitis
media) and lung infections in CF patients, are caused by
biofilm-dwelling bacteria [13–15]. The CF lung provides a
particularly attractive environment for P. aeruginosa colo-
nization and chronic lung infection and is the major causa-
tive agent of morbidity and mortality in CF patients [16].
Biofilms are now thought to be involved in 65–80% of all
microbial infections [17, 18].
Biofilm growth is thought to offer a competitive
advantage versus free-floating or planktonic growth. Bac-
teria in biofilms are more recalcitrant to disruption or
killing by surfactants, biocides, grazing predators, and
host defenses [12]. It is important to note that the biofilm
mode of growth is often associated with antimicrobial resis-
tance [12]. Studies indicate that bacteria growing in
biofilms are up to 1,000 times more resistant to antimicro-
bial challenge versus planktonically grown cells [12]. As
the knowledge of the importance of biofilms in infection
increases, perception has altered research seeking to dis-
cover new therapies to treat these infections by necessi-
tating an understanding of the mechanisms that govern
biofilm development and its role in bacterial pathogenesis.
P. aeruginosa biofilm development and its relation
to quorum sensing
P. aeruginosa biofilm formation has been divided into
various stages, including bacterial attachment and irrevers-
ible adhesion to a substratum, microcolony development,
maturation of the biofilm demonstrated by the appearance
of large structures resembling mushrooms and stalks with
water channels, and dispersion of bacterial cells from the
biofilm (Fig. 1a, b) [19]. Heterogeneous microenvironments
have been demonstrated to exist within biofilms due to
oxygen and nutrient diffusional limitations [20], and recent
evidence suggests that bacteria grow slowly within the
biofilm [17]. The biofilm is also physiologically heteroge-
neous since each bacterium within the biofilm matrix
experiences differing nutrient gradients. Bacteria within
the biofilm are thought to possess a unique phenotype quite
different from their planktonic counterparts [17].
The belief that biofilm development results from an
organized set of molecular events has led to several studies
to understand the mechanisms involved. The idea that
biofilm development is a coordinated behavior was
strengthened by evidence of a link between P. aeruginosa
QS and biofilm development [21]. This study determined
that lasI, which encodes for the synthetase responsible for
3O-C12-HSL production, is critical for mature biofilm
formation in P. aeruginosa PAO1 [21]. Mutants lacking
the lasI gene formed flat, thin biofilms with little of
the dramatic three-dimensional structures which typify
P. aeruginosa biofilms grown in a flow-through model
system. It is exciting to note that the mutant was also more
susceptible to removal by the surfactant sodium dodecyl
sulfate (SDS). Further studies have demonstrated that QS
mutant biofilms are also more susceptible to antimicrobial
challenge and phagocytosis by polymorphonuclear leuko-
cytes [7, 22]. This suggests that QS is not only important in
the development of P. aeruginosa biofilms but also in its
protective role. For example, the QS regulations of catalase
and superoxide dismutase have been demonstrated to be
important in P. aeruginosa PAO1 biofilm resistance to
hydrogen peroxide [23]. Additionally, QS inhibitors,
including a halogenated furanone synthesized by the red
algae Delisea pulchra and several derivatives of this
molecule, have been shown to not only interfere with
P. aeruginosa PAO1 biofilm development but to enhance
sensitivity to antimicrobial challenge with tobramycin
or azithromycin, presumably by interfering with QS
signaling [10].
Both flagellar and twitching motility have been demon-
strated to be involved in P. aeruginosa attachment to
surfaces and subsequent biofilm formation [24–26]. In
P. aeruginosa, twitching motility is mediated by type IV
pilin, and mutants in this pilin (ΔpilA) were unable to form
the elaborate mushroom structures typical of P. aeruginosa
biofilms. LecB, or the type II P. aeruginosa lectin, is also
involved in pilus biogenesis [27] and has been reported to
be involved in biofilm development [28]. Mutants in lecB
formed weak biofilms as compared to the wild-type
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P. aeruginosa. LecB is an important virulence determinant
in P. aeruginosa infections and has been shown in vitro
to decrease the ciliary beat frequency of the airway epithe-
lium [28]. Mutations in lecA, or the type I P. aeruginosa
lectin, resulted in thin biofilms as compared to the wild-
type P. aeruginosa [29]. It is interesting to note that a
recent study reported that LecA binds to 3O-C12-HSL [30].
Genes involved in type IV biogenesis and LecA and LecB
production are regulated by QS [9, 31].
Genetic analysis has identified several factors that are
important for normal P. aeruginosa biofilm development.
These include genes that encode structural components
of the biofilm matrix. Overproduction of alginate, an
exopolysaccharide, is the hallmark of the conversion of
P. aeruginosa to a mucoid phenotype. The appearance of
mucoid P. aeruginosa in CF infection is usually associated
with chronic infection and poor clinical outcome [32, 33].
In mucoid P. aeruginosa, alginate is a matrix component in
biofilms, and alginate-overproducing bacteria form com-
plex-structured biofilms that are highly resistant to anti-
microbials such as tobramycin [34]. Alginate also plays a
protective role in P. aerugniosa infection and has been
demonstrated to scavenge free radicals released by activat-
ed macrophages in vitro, to prevent phagocytic clearance,
and to protect from defensins [35]. The regulation of
alginate production has been well studied in P. aeruginosa
[35]. However, in nonmucoid bacteria such as P. aerugi-
nosa PAO1 and PA14, alginate is not the primary
component of the biofilm matrix [36]. Instead, two loci,
the psl (polysaccharide synthesis locus) in P. aeruginosa
PAO1 and pel genes in P. aeruginosa PA14 and PAK [36],
have been identified in in vitro assays and shown to be
involved in the production of alternative polysaccharides.
In PA14 and PAK, the pel genes produce a glucose-rich
polysaccharide that is critical for pellicle formation and
involved in biofilm development [36]. In P. aeruginosa
PAO1, the psl genes have been shown to be important in
the initiation and development of biofilms on both abiotic
and biotic surfaces, such as mucin-coated surfaces and
airway epithelial cells [36]. There is evidence that the psl
and pel genes are regulated by the two-component system
GacA/GacS and the small regulatory ribonucleic acid
a.
substratum
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b.
I
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Fig. 1 a Model of P. aeruginosa biofilm development in a flow-
through biofilm system. Bacteria are thought to attach to a surface
reversibly (I), followed by irreversible attachment (II). Microcolony
formation occurs (III), and complex three-dimensional structures know
as stalks and towers form as the biofilm matures (IV). Dispersion or
detachment of bacteria follows, which can occur by the separation of
large pieces of encased bacteria or by a process in which bacteria
become motile and tunnel out of the matrix (V). Bacteria are represented
by gray ovals, with or without flagella, and the biofilm matrix in
orange. b P. aeruginosa PAO1 expressing green fluorescent protein was
grown for 4 days in a minimal media (modified FAB). A two-
dimensional projection of the three-dimensional image is shown as a
top-down view for 2 h (I), 1 day (II), 2 days (III), 3 days (IV), and
4 days (V) after inoculation. Maximal thickness of the biofilm is
reported for each time period. Biofilm images were collected by a Leica
confocal scanning light microscopy using a 488-nm wavelength. Images
are at ×400 and represent a 250×250-μm field
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rsmZ [36]. The GacA/GacS system also positively regulates
QS in P. aeruginosa PAO1 [37]. It is interesting to note that
the gene pslB (PA2232) was demonstrated to be QS regu-
lated in the P. aeruginosa PAO1 microarray analysis,
suggesting there is a link between QS and the expression
of the psl locus [9]. In P. aeruginosa PA14, the pel genes
have also been shown to be QS regulated [38]. The role of
these novel matrix components in nonmucoid biofilm
development is of interest as nonmucoid P. aeruginosa
initially colonizes the CF lung, most likely forming
biofilms, followed by a conversion to mucoidy and chronic
infection [35]. Although the PSL and PEL polysaccharides
are now known to be an important part of the extracellular
matrix, alginate may still play a role in the nonmucoid
biofilm phenotype. For example, recent experiments
have demonstrated that alginate is critical for the protection
of P. aeruginosa PAO1, PA14, and FRD1 (a muciod
P. aeruginosa isolate) biofilms to gamma-interferon-
mediated macrophage killing in an in vitro assay [39].
There is also evidence that nonmucoid strains produce
alginate in vitro under hypoxic conditions, such as those
that are thought to exist in the CF lung and in a mouse
model of acute pneumonia [35].
Extracellular DNA is also a major component of the
biofilm matrix and has been shown to be important in the
initial and early development of P. aeruginosa biofilms
[40, 41]. Exposure of P. aeruginosa to DNaseI prevented
biofilm development in a flow-through model system and
dissolved young biofilms [41]. Further research with QS
mutants in lasI and rhlI, the genes that direct the synthesis
of the autoinducers 3O-C12-HSL and C4-HSL, respectively,
determined that QS is important in regulating extracellular
DNA release during both planktonic and biofilm growth [42].
Furthermore, PQS, the third QS autoinducer signal,
was linked to extracellular DNA release during biofilm
development [42]. The extracellular DNA has been local-
ized within the biofilm structure and varies temporally as
well as spatially. Early biofilms show large amounts of
extracellular DNA on the substratum and coating the
microcolonies, while in a mature biofilm, it is present
primarily in the stalks of mushroom structures [42]. The
source of extracellular DNA has been proposed to be due
to either prophage-induced cell lysis or the release of
membrane vesicles [42]. Previous work has demonstrated
that Pf-1 phage is produced by P. aeruginosa PAO1
biofilms [40, 43], and the genes that encode for the Pf-1
phage in P. aeruginosa PAO1 have been demonstrated to be
QS regulated during planktonic growth [9]. PQS has also
been demonstrated to be involved in membrane vesicle
formation in P. aeruginosa [44]. It is important to note that
biofilms that are deficient in extracellular DNA have been
shown to be more sensitive to SDS [42]. This suggests that
DNase I treatment, such as the current CF treatment regime
of inhaled, nebulized recombinant human DNase I, could
be important in preventing the establishment of biofilms
that are involved in chronic infection.
Several studies have reported that rhlA, one of the genes
required for rhamnolipid biosynthesis, is important in initial
P. aeruginosa biofilm development, maturation, and dis-
persion. Rhamnolipid is well known to be regulated by QS,
where the RhlR–C4-HSL complex activates the transcrip-
tion of rhlA [45]. A recent study by Pamp and Tolker-
Nielsen [46] demonstrated that rhamnolipid is essential in
the formation of the cap of the mushroom structure in
mature biofilms. The study also suggested that rhlA is
central in microcolony formation, as rhlA mutants formed
thin, flat biofilms [46]. The deletion of rhlA results in thick
biofilms with small or nonexistent water channels, suggest-
ing that rhamnolipid is involved in the maintenance of these
channels and/or dispersion of bacteria from the biofilm
matrix [47–49]. Rhamnolipid has been demonstrated to be
required for the dispersion of bacteria from the center of
mushroom structures, where bacteria “tunnel” from the
center of the macrocolony, and rhlA expression is localized
to the center of macrocolonies about to undergo dispersion
[47–49]. Bacteria that disperse from the biofilm often have
altered phenotypes and are known as colony-morphotypic
variants [50, 51]. Both P. aeruginosa PAO1 and clinical CF
isolates have been shown to follow a pattern of biofilm
development that includes dispersion, which is dependent
upon QS and the presence of Pf-1 phage [50, 51]. Small-
colony variants (SCVs) of P. aeruginosa PAO1 have been
reported to display increased biofilm-forming capability,
increased antimicrobial resistance, and enhanced dis-
semination [51], and SCVs have been isolated from CF
patients [1]. It is interesting to note that more diverse
morphotypes were reported from biofilm-dispersed CF
isolates than PAO1. This may represent an in vivo selective
adaptation process that maintains chronic infection.
Several genes encoding regulators have been identified that
are important in P. aeruginosa biofilm development. These
include gacA, the global carbon metabolism regulator crc,
the stationary phase regulator rpoS, the three-component
regulatory circuit sadARS, the response regulator for alginate
production algR, and a hybrid sensor kinase/response
regulator retS [52–57]. Mutations in gacA and crc caused
defects in mircocolony formation, resulting in thin biofilms.
As described previously, the GacA/GacS/rsmZ pathway is
involved in the regulation of the extracellular matrix
components psl and pel, which among its other influences
may contribute to its regulation of normal biofilm develop-
ment. Defects in type IV pilin production and twitching
motility in crc mutants are thought to play a role in its
defective biofilm phenotype [55].
AlgR has been previously shown to be required for full
virulence in both acute septicemia and pneumonia infection
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models. In vitro algR mutant biofilms display normal early
biofilm development but a defect in mature biofilm
development resulting in thin, patchy biofilms [52]. AlgR
is also involved in type IV-mediated twitching motility,
which may contribute to its defective biofilm pheno-
type [53]. However, further study has demonstrated that
AlgR specifically represses the rhl QS system and is
responsible for the observed mutant phenotype [52]. The
dependence of AlgR regulation of the rhl system was found
to be surface contact or biofilm dependent. Excess produc-
tion of rhamnolipid, a rhl-regulated product, was observed
in algR deletion biofilms [52]. Excess rhamnolipid produc-
tion has been previously correlated for dispersion in biofilm
development, resulting in biofilms with a similar phenotype
as the algR deletion mutants, suggesting that this is the
reason for the defect in biofilm maturation [47–49].
In contrast, rpoS mutants form thick biofilms in vitro
studies [56]. Transcriptome analysis of planktonic bacteria
demonstrated that rpoS regulates expression of nearly 800
genes in stationary phase growth [58]. It is interesting to
note that there is a circular link between rpoS and QS
regulation, and microarray analysis of the rpoS regulon in
P. aeruginosa PAO1 revealed that 40% of rpoS-regulated
genes are also QS regulated [58]. However, it is currently
unclear which of these genes may contribute to its aberrant
biofilm phenotype.
A retS mutant also formed more robust biofilms in
contrast to wild-type P. aeruginosa [57]. Microarray
analysis of a retS mutant also indicated that it is involved
in the regulation of both the psl and pel loci, which likely is
responsible for its enhanced biofilm formation in vitro [57].
The regulator retS appears to be involved in QS-mediated
phenotypes including autoinducer production via the GacA/
GacS/rsmZ pathway [57]. This regulator appears to activate
genes implicated in acute phase infection, such as the type
III secretion system, type IV pilin, and secreted virulence
molecules including exotoxin A and lipase [57]. The study
authors suggest that this gene is involved in mediating the
transition of the P. aeruginosa phenotype from an acute to
chronic phase infection [57].
Similarly, the sadARS system appears to regulate
virulence factors, such as the type III secretion system, in
addition to being crucial for normal P. aeruginosa biofilm
formation [59]. Mutation in this loci results in biofilms with
abnormal maturation, where the maintenance of the
complex three-dimensional water channels is defective.
The gene sadA has been previously demonstrated to be QS
regulated [9]. It is interesting to note that SadR possesses an
glutamate–alanine–leucine domain, which has been linked
with a phospodiesterase activity that degrades bis-(3′,5′)-
cyclic-dimeric-guanosine monophosphate (cyclic di-GMP),
producing guanosine monophosphate [59]. Increasing cy-
clic di-GMP levels have been reported to promote biofilm
development [60, 61], and several recent studies have
revealed a role for cyclic di-GMP in P. aeruginosa biofilm
formation [62–66]. In P. aeruginosa PAO1, decreased
cyclic di-GMP levels inhibited biofilm formation, while
increased cyclic di-GMP levels promoted biofilm formation
in a flow-through system [63]. Protein receptors for cyclic
di-GMP have been identified that regulate the production of
biofilm extracellular matrix components [65, 66]. For
example, cyclic-di-GMP has been demonstrated to bind to
one of the proteins in the pel operon, PelD, and modulate
production of the extrapolysaccharide matrix protein PEL
in P. aeruginosa PA14 [65]. Cyclic di-GMP has also been
demonstrated to be required for alginate biosynthesis in
mucoid P. aeruginosa, where the protein Alg44 binds
cyclic di-GMP and then activates polymerization or
transport of the alginate polysaccharide [66]. A role for
cyclic di-GMP has also been proposed in biofilm disper-
sion. Recently, a novel regulator, bdlA, has been reported
to be involved in the nutrient-induced dispersion of
P. aeruginosa PAO1 biofilms [67]. BdlA has been proposed
to transduce environmental signals that modulate the
intracellular levels of cyclic di-GMP, thereby promoting
biofilm dispersion [67].
Although there is clear evidence for the role of QS in
biofilm development (Fig. 2), other studies have been
performed with varying conclusions as to the relative
importance of QS in biofilms [10]. These inconsistencies
may be attributed to the different conditions, including
hydrodynamics and media, and/or P. aeruginosa strains
utilized in these studies. Nevertheless, several genes that
have been identified as QS regulated, including rhlA, rpoS,
sadA, and those in the denitrification pathway, have been
shown to be important in P. aeruginosa biofilm develop-
ment, maintenance, and dispersion [10, 59, 68, 69]. A recent
study of P. aeruginosa biofilms in the mouse thermal injury
model suggested that QS was not important in the formation
of biofilms in acute infection [70]; however, several previous
studies have clearly demonstrated a role for QS in this
model [71–74]. Further investigation is clearly needed to
precisely define the role of QS in both in vitro and in vivo
biofilm development.
The CF lung and P. aeruginosa biofilms
There are several lines of evidence that support the notion
that P. aeruginosa exists in a biofilm in the CF lung. These
include microscopic analysis of CF sputum, increased
antimicrobial resistance of P. aeruginosa in the CF lung,
and the ratio of the P. aeruginosa autoinducer molecules,
3O-C12-HSL and C4-HSL, in sputum from CF patients
mirrors those of biofilm-grown P. aeruginosa [75, 76].
The environment of the CF lung is thought to promote
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P. aeruginosa biofilm formation. Mutations in the CF
transmembrane regulator (CFTR) cause a defective function
of CFTR in airway epithelium and submucosal glands,
leading to decreased mucociliary clearance and altered
airway surface liquid (ASL) concentrations [77]. In addi-
tion, the nitric oxide (NO) system, involved in bacterial
killing, is impaired in CF patients as reflected by a
reduction in expression of the inducible NO synthase
(iNOS) responsible for NO production in neutrophils,
macrophages, and epithelial cells [16].
The ability of P. aeruginosa to grow anaerobically is
believed to be important in biofilm development in the CF
lung [76, 78]. Worlitzsch et al. [79] reported that oxygen
gradients exist in thick mucus plugs present in the lower
airway of CF patients. As neutrophils infiltrate and mucus
secretion increases, metabolically active bacteria and
epithelial cells consume the available oxygen, and the
surroundings quickly become oxygen limited [79]. The
conversion of P. aerugiosa to a mucoid phenotype during
the progression of chronic CF lung disease may further
restrict the diffusion of oxygen and contribute to the micro-
aerobic or anaerobic environments in CF infections. Recent
data suggest that anaerobic environments promote the con-
version of nonmucoid P. aeruginosa to mucoidy [79].
CF airway mucus has been demonstrated to support
anaerobic growth of P. aeruginosa [79]. P. aeruginosa is
able to grow anaerobically using the alternative electron
acceptors nitrate, nitrite, and nitrous oxide through a
respiratory process termed denitrification [80]. Nitrate and
nitrite concentrations in CF sputum are able to support
anaerobic respiration of P. aeruginosa [79, 81–83]. In the
absence of nitrate or nitrite, arginine can be catabolized to
ornithine using substrate-level phosphorylation and used
as an energy source for anaerobic growth [84, 85].
P. aeruginosa can also use pyruvate to sustain long-term
survival, but this fermentation process can not support
growth of the bacterium, under hypoxic conditions [86].
Anaerobic conditions promote biofilm development in both
P. aeruginosa PAO1 and in CF isolates, suggesting that
P. aeruginosa readily adapts and perhaps favors anaerobic
biofilm growth in vivo [87].
Anaerobiosis is not only important in P. aeruginosa
survival in the CF lung environment but also within the
biofilm itself. Within an aerobically grown biofilm, oxygen
depletion has been reported to occur within 30 μm of the
surface of the biofilm [20]. As P. aeruginosa forms biofilms
in the CF mucus, the bacteria undergo a switch from an
aerobic to an anaerobic metabolism [78]. P. aeruginosa
existing within the biofilms experience oxygen gradients, in
which the base and the center of the biofilm are anaerobic
substratum
I II III IV V
• Rhamnolipid (rhlA,B)
• sadA
• Matrix components: 




• Type IV fimbriae (twitching motility)
• rhlA
• lasI




Fig. 2 Genes and factors implicated during P. aeruginosa biofilm development that are QS regulated. Genes and factors are listed below the
developmental stage of biofilm formation in which they have been reported to be important
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[20, 79, 88]. Genes involved in denitrification have been
identified as QS regulated, suggesting a link between
anaerobic metabolism and QS [9]. A further study reported
that during anaerobic biofilm growth of P. aeruginosa, the
rhl QS system was required for proper balance of the
denitrification pathway [89]. Dysregulation of the pathway
resulted in the accumulation of toxic intermediates, such as
nitrite and nitrous oxide, which caused cell death to occur
within the biofilm.
It is interesting to note that nitrous oxide has been
demonstrated to be a signal involved in P. aeruginosa
biofilm dispersal [90]. Exposure of P. aeruginosa biofilms
to NO in combination with antimicrobials or SDS enhanced
the activity of these agents. In addition, recent data suggest
that mucoid P. aeruginosa CF isolates are exquisitely
sensitive to nitrite due to an inability to remove the toxic
accumulation of NO [91]. The fact that iNOS activity
decreases as the chronic CF infection progresses may
contribute to the ability of P. aeruginosa to persist as a
biofilm.
The thick mucus present in the airways of CF lungs
provides a diffusion-restricted environment. A recent study
demonstrated that in ASL, P. aeruginosa PAO1 formed
macrocolonies resembling biofilms dependent upon the
concentration of solids [92]. In normal ASL, PAO1 failed to
form macrocolonies. However, in concentrated ASL mim-
icking ASL found in CF patients, PAO1 readily formed
biofilms under either aerobic or anaerobic conditions.
Furthermore, the formation of these macrocolonies was
dependent upon a functional las QS system. The mutation
in lasI abrogated macrocolony formation. Diffusion studies
demonstrated that concentrated ASL greatly restricted the
movement of 3O-C12-HSL, the product of the lasI gene.
The constrained microenvironment in the CF ASL is
thought to promote P. aeruginosa biofilm formation by
concentrating 3O-C12-HSL and activating QS-regulated
factors involved in biofilm development.
Quorum sensing in P. aeruginosa pathogenesis
and implications in vivo
Both in vitro and in vivo models have clearly demonstrated
the importance of QS in P. aeruginosa pathogenesis.
Numerous models of infection, including plant, invertebrate,
and animal models, have supported the premise that QS
contributes to P. aeruginosa pathogenesis [71–74, 93–101].
In animal models of lung pathogenesis, including the mouse
model of acute pneumonia, the mouse model of chronic
lung infection, and the rat chronic lung infection model,
lasR, lasI, and rhlI have been demonstrated to be required
for virulence [73, 93, 102–105]. Other QS-regulated factors,
such as type IV pilin biosynthesis and type III secretion
pathways, have been clearly linked to P. aeruginosa
pathogenesis [9, 98].
Evidence exists that P. aeruginosa QS is active in CF
patients. Several studies have reported the presence of
transcripts for known QS regulators and QS-regulated
genes in CF patient samples, suggesting a role for QS in
vivo. Transcripts for lasR, lasI, lasA, lasB, and toxA have
been detected in sputa samples from chronically infected
CF patients [106, 107]. There appeared to be a correlation
of lasR to the expression lasI, lasR, lasA, lasB, and toxA,
and as lasR is known to regulate expression of these genes
in vitro, this relationship suggested that lasR also regulates
these genes in vivo [106]. A further study reported a
statistically significant correlation between lasR and algD
transcription [106]. This suggested that lasR might to some
extent regulate algD or, alternatively, be activated by a
common environmental trigger in vivo. AlgD catalyzes the
first step in alginate biosynthesis, which is responsible for
the mucoid phenotype often observed in clinical isolates
from P. aeruginosa chronically infected CF patients [108].
The autoinducer molecules 3O-C12-HSL, C4-HSL, and
PQS are also present in CF sputa samples, and PQS has
been detected in bronchoalveolar lavage fluid and muco-
las and rhl QS systems
Biofilm formation and 
maintenance:
lasI, lasR, rhlR, rhlAB, 
rpoS, pslA-K, PA5057-5059
Antibiotic sensitivity:
mexAB, lasI, rhlI, pqs
Virulence:
lasI  lasAB  rhlAB







Fig. 3 Quorum sensing regu-
lates multiple phenotypes in
P. aeruginosa. Several genes
that have been identified to
contribute to each phenotype
are listed
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purulent fluid from distal airways of end-stage lungs
removed at transplant in CF patients [106, 109, 110].
Curiously, the isolation of P. aeruginosa from acute and
chronic infections, including the infected CF lung, with
defects in QS suggests that the role of QS is diminished or
perhaps not important in vivo [111, 112]. The dichotomy
between the isolation of QS-deficient P. aeruginosa from
infections and the importance of QS in the infectious
process has been a conundrum. This is important as QS is
thought to be an attractive target for the development of
novel therapeutics [78, 113]. However, a recent study
reported that in instances of high QS activity, spontaneous
QS mutants, usually in the main regulator lasR, occur
[112]. Mutants in lasR are more resistant to cell lysis and
death at high cell densities and at alkaline pH. These “social
cheaters” appear to have a competitive advantage over
P. aeruginosa with intact QS systems. The appearance of
QS mutants suggests, in contrast to previous belief, high
QS activity due to the metabolic burden QS places on
the bacteria.
Summary
P. aeruginosa possesses many traits, including intrinsic
antimicrobial resistance, ability to form biofilms, arsenal of
virulence products, and metabolic versatility that contribute
to its ability to colonize and persist in acute and chronic
infections such as those of CF patients. In P. aeruginosa,
QS regulates many of these phenotypes (Fig. 3). The CF
lung presents an ideal niche for P. aeruginosa. Dysregula-
tion in mucocilliary clearance and NO-mediated killing are
thought to contribute to colonization of P. aeruginosa in the
CF airways. A restricted microenvironment due to thick
airway liquid results in decreased oxygen concentrations
and increased localized autoinducer concentrations that
have been demonstrated to promote biofilm development.
The biofilm mode of growth subsequently provides
protection against numerous host factors and antimicrobial
challenge. Due to its role in pathogenesis, biofilm devel-
opment, and antimicrobial resistance, QS represents an
attractive target for the development of novel therapeutics.
Further understanding of the QS mechanisms involved in
these phenotypes will substantially aid in this goal.
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